Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort

Biologic medications are recommended for treatment of moderately-to-severely active Crohn disease (CD) or ulcerative colitis (UC) in children. However, many patients require sequential biologic treatment because of nonresponse or loss of response to the initial biologic. METHODS: We analyzed pediatr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Jess L., Liu, Chunyan, King, Eileen C., Bass, Julie A., Patel, Ashish S., Tung, Jeanne, Chen, Shiran, Lissoos, Trevor, Candela, Ninfa, Saeed, Shehzad, Colletti, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles: Gastroenterology: Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097486/
https://www.ncbi.nlm.nih.gov/pubmed/36804501
http://dx.doi.org/10.1097/MPG.0000000000003734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097486/
https://www.ncbi.nlm.nih.gov/pubmed/36804501
http://dx.doi.org/10.1097/MPG.0000000000003734

Ejemplares similares